In the past, hydrogen sulfide (H 2 S) was recognized as a toxic and dangerous gas; in recent years, with increased research, we have discovered that H 2 S can act as an endogenous regulatory transmitter. In mammals, H 2 S-catalyzing enzymes, such as cystathionine-β-synthase, cystathionine-γ-lyase, and 3-mercaptopyruvate sulfurtransferase, are differentially expressed in a variety of tissues and affect a variety of biological functions, such as transcriptional and posttranslational modification of genes, activation of signaling pathways in the cell, and metabolic processes in tissues, by producing H 2 S. Various preclinical studies have shown that H 2 S affects physiological and pathological processes in the body. However, a detailed systematic summary of these roles in health and disease is lacking. Therefore, this review provides a thorough overview of the physiological roles of H 2 S in different systems and the diseases associated with disorders of H 2 S metabolism, such as ischemia-reperfusion injury, hypertension, neurodegenerative diseases, inflammatory bowel disease, and cancer. Meanwhile, this paper also introduces H 2 S donors and novel release modes, as well as the latest preclinical experimental results, aiming to provide researchers with new ideas to discover new diagnostic targets and therapeutic options.
Keyphrases
- gene expression
- public health
- ischemia reperfusion injury
- cell therapy
- healthcare
- mental health
- transcription factor
- signaling pathway
- blood pressure
- health information
- oxidative stress
- papillary thyroid
- single cell
- health promotion
- genome wide
- stem cells
- dna methylation
- human health
- pi k akt
- room temperature
- bone marrow
- mesenchymal stem cells
- risk assessment
- induced apoptosis
- ulcerative colitis
- genome wide identification
- genome wide analysis